Yudai Kabata

CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells

J. Jackow, Zongyou Guo, C. Hansen et al. · Proceedings of the National Academy of Sciences · 2019 · 115 citations · Full text

Life Sciences, Biotechnology, Genetics +11

Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab

Takeshi Nakahara, Kenji Izuhara, Daisuke Onozuka et al. · Medicine · 2020 · 17 citations · Full text

Medicine, Dermatology, Immunology +17

The ability of biomarkers to assess the severity of atopic dermatitis

Takeshi Nakahara, Daisuke Onozuka, Satoshi Nunomura et al. · Journal of Allergy and Clinical Immunology Global · 2023 · 16 citations · Full text

Medicine, Dermatology, Immunology +17

312 CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells

J. Jackow, Zongyou Guo, Hasan Erbil Abaci et al. · Journal of Investigative Dermatology · 2019 · 14 citations

Life Sciences, Biotechnology, Genetics +14

Diverse dystonin gene mutations cause distinct patterns of <i>Dst</i> isoform deficiency and phenotypic heterogeneity in <i>D</i> <i>ystonia musculorum</i> mice

Nozomu Yoshioka, Yudai Kabata, Momona Kuriyama et al. · Disease Models & Mechanisms · 2020 · 12 citations · Full text

Medicine, Genetics, Neurology +13